This View Point webinar with Dr. Tianwei (Ellen) Zhou was recorded May 19, 2020. Dr. Zhou spoke about Retinopathy of Prematurity (ROP), a blinding eye disease that affects many premature babies. In this talk, she discusses what ROP is, its impact on patients’ lives, current treatments and what needs to be done in the future. Dr. Tainwei’s upcoming project on ROP is supported by the FBC Clinician-Scientist Emerging Leader (CSEL) Award.
View Point is proudly presented by Bayer and supported by Allergan-Abvie, Biogen, Janssen, Novartis, AGTC, MeiraGTx and the SickKids Foundation. Our national partner in accessibility is AMI.
To learn more visit [ Ссылка ]-...
STAY CONNECTED
Twitter: [ Ссылка ]
Facebook: [ Ссылка ]...
Instagram: [ Ссылка ]...
Sign-up for our monthly e-newsletter: [ Ссылка ]...
CONTACT US
General Inquiries: info@fightingblindness.ca
Health Information Line: 1.888.626.2995 | healthinfo@fightingblindness.ca
ABOUT FIGHTING BLINDNESS CANADA Fighting Blindness Canada (FBC) is Canada’s leading private funder of vision research. We offer hope to Canadians by identifying the best, most promising research that is driving treatments and cures for blinding eye diseases, and by raising and stewarding funds to support this essential, sight-saving research. All of the research and educational initiatives we fund supports our goals of understanding why vision loss occurs, how it can be slowed or stopped, and how sight can be restored. Learn more about Fighting Blindness Canada: [ Ссылка ]...
